{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:41:22Z","timestamp":1781199682463,"version":"3.54.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["T11-712\/19-N"],"award-info":[{"award-number":["T11-712\/19-N"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund","doi-asserted-by":"publisher","award":["COVID-190126"],"award-info":[{"award-number":["COVID-190126"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201400006C"],"award-info":[{"award-number":["HHSN272201400006C"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The antibody response magnitude and kinetics may impact clinical severity, serological diagnosis and long-term protection of COVID-19, which may play a role in why children experience lower morbidity. We therefore\u00a0tested samples from 122 children in Hong Kong with symptomatic (<jats:italic>n<\/jats:italic>\u2009=\u200978) and asymptomatic (<jats:italic>n<\/jats:italic>\u2009=\u200944) SARS-CoV-2 infections up to 200 days post infection, relative to 71 infected adults (symptomatic <jats:italic>n<\/jats:italic>\u2009=\u200961, and asymptomatic <jats:italic>n<\/jats:italic>\u2009=\u200910), and negative controls (<jats:italic>n<\/jats:italic>\u2009=\u200948). We assessed serum IgG antibodies to a 14-wide antigen panel of structural and accessory proteins by Luciferase Immuno-Precipitation System (LIPS) assay and circulating cytokines. Infected children have lower levels of Spike, Membrane, ORF3a, ORF7a, ORF7b antibodies, comparable ORF8 and elevated E-specific antibodies than adults. Combination of two unique antibody targets, ORF3d and ORF8, can accurately discriminate SARS-CoV-2 infection in children. Principal component analysis reveals distinct pediatric serological signatures, and the highest contribution to variance from adults are antibody\u00a0responses to non-structural proteins ORF3d, NSP1, ORF3a and ORF8. From a diverse panel of cytokines that can modulate immune priming and relative inflammation, IL-8, MCP-1 and IL-6 correlate with the magnitude of pediatric antibody specificity and severity. Antibodies to SARS-CoV-2 internal proteins may become an important sero surveillance tool of infection with the roll-out of vaccines in the pediatric population.<\/jats:p>","DOI":"10.1038\/s41467-022-30699-5","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T10:11:07Z","timestamp":1653559867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["SARS-CoV-2 accessory proteins reveal distinct serological signatures in children"],"prefix":"10.1038","volume":"13","author":[{"given":"Asmaa","family":"Hachim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7541-4262","authenticated-orcid":false,"given":"Haogao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otared","family":"Kavian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike Y. W.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9256-4799","authenticated-orcid":false,"given":"Wai Hung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5471-9139","authenticated-orcid":false,"given":"Yat Sun","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen T. Y.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4382-2445","authenticated-orcid":false,"given":"David S. C.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris K. P.","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fionn N. L.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6688-9637","authenticated-orcid":false,"given":"Eric H. Y.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0418-9707","authenticated-orcid":false,"given":"Gaya K.","family":"Amarasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham J.","family":"Qavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel M. S.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9101-7953","authenticated-orcid":false,"given":"Leo L. M.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-5995","authenticated-orcid":false,"given":"J. S. Malik","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0768-9926","authenticated-orcid":false,"given":"Sophie A.","family":"Valkenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Kavian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"30699_CR1","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","volume":"52","author":"N Vabret","year":"2020","unstructured":"Vabret, N. et al. Immunology of COVID-19: current state of the science. Immunity 52, 910\u2013941 (2020).","journal-title":"Immunity"},{"key":"30699_CR2","doi-asserted-by":"crossref","unstructured":"Jones, T. C. et al. Estimating infectiousness throughout SARS-CoV-2 infection course. Science 373, eabi5273 (2021).","DOI":"10.1126\/science.abi5273"},{"key":"30699_CR3","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1001\/jama.2020.8707","volume":"323","author":"S Bunyavanich","year":"2020","unstructured":"Bunyavanich, S., Do, A. & Vicencio, A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA 323, 2427\u20132429 (2020).","journal-title":"JAMA"},{"key":"30699_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jmv.25715","volume":"92","author":"GJ Gorse","year":"2020","unstructured":"Gorse, G. J., Donovan, M. M. & Patel, G. B. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses. J. Med. Virol. 92, 512\u2013517 (2020).","journal-title":"J. Med. Virol."},{"key":"30699_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22236-7","volume":"12","author":"KJ Selva","year":"2021","unstructured":"Selva, K. J. et al. Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat. Commun. 12, 2037 (2021).","journal-title":"Nat. Commun."},{"key":"30699_CR6","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3389\/fimmu.2020.01518","volume":"11","author":"TL Freeman","year":"2020","unstructured":"Freeman, T. L. & Swartz, T. H. Targeting the NLRP3 inflammasome in severe COVID-19. Front. Immunol. 11, 1518 (2020).","journal-title":"Front. Immunol."},{"key":"30699_CR7","doi-asserted-by":"crossref","unstructured":"Loske, J. et al. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat. Biotechnol. 40, 319\u2013324 (2022).","DOI":"10.1038\/s41587-021-01037-9"},{"key":"30699_CR8","unstructured":"Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, eabd4585 (2020)."},{"key":"30699_CR9","doi-asserted-by":"crossref","unstructured":"Zimmermann, P. & Curtis, N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch. Dis. Child. 106, 429\u2013439 (2021).","DOI":"10.1136\/archdischild-2020-320338"},{"key":"30699_CR10","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cell.2020.04.042","volume":"181","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection. Cell 181, 969\u2013977 (2020).","journal-title":"Cell"},{"key":"30699_CR11","doi-asserted-by":"crossref","unstructured":"Valverde, I. et al. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe. Circulation 143, 21\u201332 (2021).","DOI":"10.1161\/CIRCULATIONAHA.120.050065"},{"key":"30699_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1056\/NEJMc2007617","volume":"383","author":"N Parri","year":"2020","unstructured":"Parri, N., Lenge, M. & Buonsenso, D., Coronavirus Infection in Pediatric Emergency Departments Research, G. Children with Covid-19 in pediatric emergency departments in Italy. N. Engl. J. Med. 383, 187\u2013190 (2020).","journal-title":"N. Engl. J. Med."},{"key":"30699_CR13","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu, Z. & McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the chinese center for disease control and prevention. JAMA 323, 1239\u20131242 (2020).","journal-title":"JAMA"},{"key":"30699_CR14","doi-asserted-by":"publisher","first-page":"e0237828","DOI":"10.1371\/journal.pone.0237828","volume":"15","author":"Z Rikhtegaran Tehrani","year":"2020","unstructured":"Rikhtegaran Tehrani, Z. et al. Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays. PLoS ONE 15, e0237828 (2020).","journal-title":"PLoS ONE"},{"key":"30699_CR15","doi-asserted-by":"publisher","first-page":"e221313","DOI":"10.1001\/jamanetworkopen.2022.1313","volume":"5","author":"ZQ Toh","year":"2022","unstructured":"Toh, Z. Q. et al. Comparison of seroconversion in children and adults with mild COVID-19. JAMA Netw. Open 5, e221313 (2022).","journal-title":"JAMA Netw. Open"},{"key":"30699_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jinf.2021.03.015","volume":"82","author":"RJ Harris","year":"2021","unstructured":"Harris, R. J. et al. Serological surveillance of SARS-CoV-2: six-month trends and antibody response in a cohort of public health workers. J. Infect. 82, 162\u2013169 (2021).","journal-title":"J. Infect."},{"key":"30699_CR17","doi-asserted-by":"crossref","unstructured":"Oeser, C. et al. Large increases in SARS-CoV-2 seropositivity in children in England: effects of the delta wave and vaccination. J. Infect. 84, 418\u2013467 (2022).","DOI":"10.1016\/j.jinf.2021.11.019"},{"key":"30699_CR18","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.jinf.2021.08.012","volume":"83","author":"N Allen","year":"2021","unstructured":"Allen, N. et al. Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals. J. Infect. 83, e9\u2013e10 (2021).","journal-title":"J. Infect."},{"key":"30699_CR19","unstructured":"Weisberg, S. P. et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat. Immunol. 22, 25\u201331 (2020)."},{"key":"30699_CR20","doi-asserted-by":"crossref","unstructured":"Pisanic, N. et al. COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva. J. Clin. Microbiol. 59, e02204-20 (2020).","DOI":"10.1128\/JCM.02204-20"},{"key":"30699_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/infdis\/jiab256","volume":"224","author":"H Alkharaan","year":"2021","unstructured":"Alkharaan, H. et al. Persisting salivary IgG against SARS-CoV-2 at 9 months after mild COVID-19: a complementary approach to population surveys. J. Infect. Dis. 224, 407\u2013414 (2021).","journal-title":"J. Infect. Dis."},{"key":"30699_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41590-021-01089-8","volume":"23","author":"AC Dowell","year":"2022","unstructured":"Dowell, A. C. et al. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nat. Immunol. 23, 40\u201349 (2022).","journal-title":"Nat. Immunol."},{"key":"30699_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02184-1","volume":"19","author":"C Dobano","year":"2021","unstructured":"Dobano, C. et al. Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain. BMC Med. 19, 309 (2021).","journal-title":"BMC Med."},{"key":"30699_CR24","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/s41590-020-0773-7","volume":"21","author":"A Hachim","year":"2020","unstructured":"Hachim, A. et al. ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nat. Immunol. 21, 1293\u20131301 (2020).","journal-title":"Nat. Immunol."},{"key":"30699_CR25","unstructured":"Shrock, E. et al. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science 370, eabd4250 (2020)."},{"key":"30699_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17488-8","volume":"11","author":"HW Jiang","year":"2020","unstructured":"Jiang, H. W. et al. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses. Nat. Commun. 11, 3581 (2020).","journal-title":"Nat. Commun."},{"key":"30699_CR27","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1016\/j.molcel.2021.04.008","volume":"81","author":"L Martin-Sancho","year":"2021","unstructured":"Martin-Sancho, L. et al. Functional landscape of SARS-CoV-2 cellular restriction. Mol Cell. 81, 2656\u20132668.e8. https:\/\/doi.org\/10.1016\/j.molcel.2021.04.008 (2021).","journal-title":"Mol Cell"},{"key":"30699_CR28","doi-asserted-by":"publisher","first-page":"108185","DOI":"10.1016\/j.celrep.2020.108185","volume":"32","author":"Y Konno","year":"2020","unstructured":"Konno, Y. et al. SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant. Cell Rep. 32, 108185 (2020).","journal-title":"Cell Rep."},{"key":"30699_CR29","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1080\/22221751.2020.1780953","volume":"9","author":"CK Yuen","year":"2020","unstructured":"Yuen, C. K. et al. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerg. Microbes Infect. 9, 1418\u20131428 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"30699_CR30","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Iota. Proc. Natl Acad. Sci. USA 118, e2024202118 (2021).","DOI":"10.1073\/pnas.2024202118"},{"key":"30699_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(20)31757-8","volume":"396","author":"BE Young","year":"2020","unstructured":"Young, B. E. et al. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet 396, 603\u2013611 (2020).","journal-title":"Lancet"},{"key":"30699_CR32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"30699_CR33","doi-asserted-by":"crossref","unstructured":"Yu, S. et al. SARS-CoV-2 spike engagement of ACE2 primes S2\u2019 site cleavage and fusion initiation. Proc. Natl Acad. Sci. USA 119, e2111199119 (2022).","DOI":"10.1073\/pnas.2111199119"},{"key":"30699_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22905-7","volume":"12","author":"I Jungreis","year":"2021","unstructured":"Jungreis, I., Sealfon, R. & Kellis, M. SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes. Nat. Commun. 12, 2642 (2021).","journal-title":"Nat. Commun."},{"key":"30699_CR35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00299-020-02654-5","volume":"40","author":"T Imamura","year":"2021","unstructured":"Imamura, T., Isozumi, N., Higashimura, Y., Ohki, S. & Mori, M. Production of ORF8 protein from SARS-CoV-2 using an inducible virus-mediated expression system in suspension-cultured tobacco BY-2 cells. Plant Cell Rep. 40, 433\u2013436 (2021).","journal-title":"Plant Cell Rep."},{"key":"30699_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-2-59","volume":"2","author":"S Sanga","year":"2009","unstructured":"Sanga, S., Broom, B. M., Cristini, V. & Edgerton, M. E. Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family. BMC Med. Genomics 2, 59 (2009).","journal-title":"BMC Med. Genomics"},{"key":"30699_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/mnras\/225.1.155","volume":"225","author":"G Fasano","year":"1987","unstructured":"Fasano, G. & Franceschini, A. A multidimensional version of the Kolmogorov\u2013Smirnov test. Monthly Not. R. Astronomical Soc. 225, 155\u2013170 (1987).","journal-title":"Monthly Not. R. Astronomical Soc."},{"key":"30699_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","volume":"6","author":"L Yang","year":"2021","unstructured":"Yang, L. et al. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct. Target Ther. 6, 255 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"30699_CR39","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1056\/NEJMoa2101643","volume":"385","author":"PO Guimaraes","year":"2021","unstructured":"Guimaraes, P. O. et al. Tofacitinib in patients hospitalized with Covid-19 pneumonia. N. Engl. J. Med. 385, 406\u2013415 (2021).","journal-title":"N. Engl. J. Med."},{"key":"30699_CR40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41392-020-00433-y","volume":"5","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. Scoring cytokine storm by the levels of MCP-3 and IL-8 accurately distinguished COVID-19 patients with high mortality. Signal Transduct. Target Ther. 5, 292 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"30699_CR41","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle, D. M. et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26, 1636\u20131643 (2020).","journal-title":"Nat. Med."},{"key":"30699_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24938-4","volume":"12","author":"CA Cohen","year":"2021","unstructured":"Cohen, C. A. et al. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection. Nat. Commun. 12, 4678 (2021).","journal-title":"Nat. Commun."},{"key":"30699_CR43","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.3389\/fmicb.2020.02086","volume":"11","author":"D Schoeman","year":"2020","unstructured":"Schoeman, D. & Fielding, B. C. Is there a link between the pathogenic human coronavirus envelope protein and immunopathology? A review of the literature. Front. Microbiol. 11, 2086 (2020).","journal-title":"Front. Microbiol."},{"key":"30699_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-021-04345-x","volume":"602","author":"M Yoshida","year":"2022","unstructured":"Yoshida, M. et al. Local and systemic responses to SARS-CoV-2 infection in children and adults. Nature 602, 321\u2013327 (2022).","journal-title":"Nature"},{"key":"30699_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41590-020-00826-9","volume":"22","author":"SP Weisberg","year":"2021","unstructured":"Weisberg, S. P. et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat. Immunol. 22, 25\u201331 (2021).","journal-title":"Nat. Immunol."},{"key":"30699_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/infdis\/jiaa161","volume":"222","author":"AS Monto","year":"2020","unstructured":"Monto, A. S. et al. Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan. J. Infect. Dis. 222, 9\u201316 (2020).","journal-title":"J. Infect. Dis."},{"key":"30699_CR47","doi-asserted-by":"crossref","unstructured":"Ng, K. W. et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science 370, 1339\u20131343 (2020).","DOI":"10.1126\/science.abe1107"},{"key":"30699_CR48","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/s41591-020-1083-1","volume":"26","author":"AWD Edridge","year":"2020","unstructured":"Edridge, A. W. D. et al. Seasonal coronavirus protective immunity is short-lasting. Nat. Med. 26, 1691\u20131693 (2020).","journal-title":"Nat. Med."},{"key":"30699_CR49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"JF Chan","year":"2020","unstructured":"Chan, J. F. et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 9, 221\u2013236 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"30699_CR50","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022","volume":"5","author":"Z Toh","year":"2022","unstructured":"Toh, Z. Q. et al. Comparison of Seroconversion in Children and Adults With Mild COVID-19. JAMA Netw Open. 5, e221313. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022 (2022).","journal-title":"JAMA Netw Open."},{"key":"30699_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26479-2","volume":"12","author":"J Wei","year":"2021","unstructured":"Wei, J. et al. Anti-spike antibody response to natural SARS-CoV-2 infection in the general population. Nat. Commun. 12, 6250 (2021).","journal-title":"Nat. Commun."},{"key":"30699_CR52","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick, L. C. et al. Antibody-dependent enhancement of severe dengue disease in humans. Science 358, 929\u2013932 (2017).","journal-title":"Science"},{"key":"30699_CR53","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1016\/j.cell.2021.05.032","volume":"184","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies. Cell 184, 3452\u20133466.e3418 (2021).","journal-title":"Cell"},{"key":"30699_CR54","doi-asserted-by":"crossref","unstructured":"Ravichandran, S. et al. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19. Nat. Immunol. 22, 1452\u20131464 (2021).","DOI":"10.1038\/s41590-021-01051-8"},{"key":"30699_CR55","doi-asserted-by":"crossref","unstructured":"Rodda, L. B. et al. Functional SARS-CoV-2-specific immune memory persists after mild COVID-19. Cell 184, 169\u2013183 (2021).","DOI":"10.1016\/j.cell.2020.11.029"},{"key":"30699_CR56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s10020-020-00230-x","volume":"26","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19. Mol. Med. 26, 97 (2020).","journal-title":"Mol. Med."},{"key":"30699_CR57","doi-asserted-by":"publisher","unstructured":"Hamdorf, M. et al. The unique ORF8 protein from SARS-CoV-2 binds to human dendritic cells and induces a hyper-inflammatory cytokine storm. Preprint at Lancet https:\/\/doi.org\/10.2139\/ssrn.3986016 (2021).","DOI":"10.2139\/ssrn.3986016"},{"key":"30699_CR58","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","volume":"22","author":"M Zheng","year":"2021","unstructured":"Zheng, M. et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat. Immunol. 22, 829\u2013838 (2021).","journal-title":"Nat. Immunol."},{"key":"30699_CR59","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/d41586-021-02796-w","volume":"598","author":"SChina\u2019s Mallapaty","year":"2021","unstructured":"Mallapaty, S. China\u2019s COVID vaccines have been crucial\u2014now immunity is waning. Nature 598, 398\u2013399 (2021).","journal-title":"Nature"},{"key":"30699_CR60","doi-asserted-by":"crossref","unstructured":"Mok, C. et al. Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong. Respirology 27, 301\u2013310 (2022).","DOI":"10.1111\/resp.14191"},{"key":"30699_CR61","doi-asserted-by":"crossref","unstructured":"Dorschug, A. et al. Comparative assessment of sera from individuals after S-gene RNA-based SARS-CoV-2 vaccination with spike-protein-based and nucleocapsid-based serological assays. Diagnostics 11, 426 (2021).","DOI":"10.3390\/diagnostics11030426"},{"key":"30699_CR62","doi-asserted-by":"crossref","unstructured":"Lam, J. Y. et al. Loss of orf3b in the circulating SARS-CoV-2 strains. Emerg. Microbes Infect. 9, 2685\u20132696 (2020).","DOI":"10.1080\/22221751.2020.1852892"},{"key":"30699_CR63","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.coviro.2021.08.006","volume":"50","author":"A Hachim","year":"2021","unstructured":"Hachim, A., Kavian, N. & Valkenburg, S. A. Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets. Curr. Opin. Virol. 50, 139\u2013146 (2021).","journal-title":"Curr. Opin. Virol."},{"key":"30699_CR64","doi-asserted-by":"crossref","unstructured":"Burbelo, P. D., Ching, K. H., Klimavicz, C. M. & Iadarola, M. J. Antibody profiling by luciferase immunoprecipitation systems (LIPS). J. Vis. Exp. (JoVE) 32, e1549 (2009).","DOI":"10.3791\/1549"},{"key":"30699_CR65","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","volume":"26","author":"F Amanat","year":"2020","unstructured":"Amanat, F. et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat. Med. 26, 1033\u20131036 (2020).","journal-title":"Nat. Med."},{"key":"30699_CR66","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/eji.202048715","volume":"50","author":"L Haljasmagi","year":"2020","unstructured":"Haljasmagi, L. et al. LIPS method for the detection of SARS-CoV-2 antibodies to spike and nucleocapsid proteins. Eur. J. Immunol. 50, 1234\u20131236 (2020).","journal-title":"Eur. J. Immunol."},{"key":"30699_CR67","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/infdis\/jiaa273","volume":"222","author":"PD Burbelo","year":"2020","unstructured":"Burbelo, P. D. et al. Sensitivity in detection of antibodies to nucleocapsid and spike proteins of severe acute respiratory syndrome coronavirus 2 in patients with coronavirus disease 2019. J. Infect. Dis. 222, 206\u2013213 (2020).","journal-title":"J. Infect. Dis."},{"key":"30699_CR68","doi-asserted-by":"crossref","unstructured":"Grzelak, L. et al. A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations. Sci. Transl. Med. 12, eabc3103 (2020).","DOI":"10.1126\/scitranslmed.abc3103"},{"key":"30699_CR69","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265\u2013269 (2020).","journal-title":"Nature"},{"key":"30699_CR70","unstructured":"Roweis, S. EM Algorithms for PCA and Sensible PCA (1997)."},{"key":"30699_CR71","doi-asserted-by":"crossref","unstructured":"Stacklies, W., Redestig, H., Scholz, M., Walther D. & Selbig, J. Methods\u2014A Bioconductor Package Providing PCA Methods for Incomplete Data (Bioinformatics, 2007).","DOI":"10.1093\/bioinformatics\/btm069"},{"key":"30699_CR72","doi-asserted-by":"crossref","unstructured":"L\u00ea, S., Josse, J. & Husson, F. FactoMineR: an R Package for Multivariate Analysis (2008).","DOI":"10.18637\/jss.v025.i01"},{"key":"30699_CR73","unstructured":"R project. https:\/\/cran.rproject.org\/web\/packages\/factoextra\/index.html (2020)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30699-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30699-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30699-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:36:28Z","timestamp":1669311388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30699-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["30699"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-30699-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"assertion":[{"value":"6 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.H., N.K., L.L.M.P., J.S.M.P., and S.A.V. have filed an IDF (US 63\/016,898) for the use of ORF8 and ORF3d as diagnostics of SARS-CoV-2 infection. M.M. produced ORF8 by patent process based on US Patents 8,507,220 and 8,586,826. Other authors have no declaration of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2951"}}